Details for New Drug Application (NDA): 017923
✉ Email this page to a colleague
NDA 017923 describes MELLARIL-S, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the MELLARIL-S profile page.
The generic ingredient in MELLARIL-S is thioridazine. There are eighteen drug master file entries for this compound. Additional details are available on the thioridazine profile page.
The generic ingredient in MELLARIL-S is thioridazine. There are eighteen drug master file entries for this compound. Additional details are available on the thioridazine profile page.
Summary for 017923
| Tradename: | MELLARIL-S |
| Applicant: | Novartis |
| Ingredient: | thioridazine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017923
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | EQ 25MG HYDROCHLORIDE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | EQ 100MG HYDROCHLORIDE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
